Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
FertiStart
- Development stage
- Phase 3
- Lead developer
- IBSA
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Subcutaneous, Intramuscular
01
Overview
FertiStart is a highly purified human menopausal gonadotrophin (hMG) preparation containing follicle-stimulating hormone (FSH) and luteinizing hormone (LH) in a 1:1 ratio. Derived from the urine of postmenopausal women, it is developed by IBSA (Institut Biochimique SA) for use in fertility treatments. The drug mimics the physiological actions of endogenous gonadotrophins by binding to their respective G protein-coupled receptors on the ovaries. Specifically, the FSH component promotes the recruitment and maturation of ovarian follicles, while the LH component supports steroidogenesis, particularly the production of androgens that are subsequently aromatized to estrogens. FertiStart is primarily indicated for the induction of ovulation in women with hypothalamic-pituitary dysfunction and for the stimulation of multifollicular development in patients undergoing assisted reproductive technologies (ART), such as in vitro fertilization (IVF).
- Brand names
- FertiStart
- Other names
- menotropinhuman menopausal gonadotrophinhMGhMG HP
02
Targets
FSHR (Follicle-stimulating hormone receptor)LHCGR (Luteinizing hormone/choriogonadotropin receptor)
Beyond the preview
Go deeper on FertiStart.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on FertiStart.